Products for Research Use Only
RegisterLogin

CDK9-IN-37

CAT: 0013-GTR19257959-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19257959-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-37 (Compound 24) is a CDK9 inhibitor with high selectivity, demonstrating an EC50 of 5.5 nM and minimal inhibition of other CDK subtypes. It shows significant antiproliferative activity against acute myeloid leukemia cells MOLM-13, with an IC50 of 0.034 μM. CDK9-IN-37 suppresses CDK9 signaling, reducing RNAP II CTD (Ser2) phosphorylation, downregulating the anti-apoptotic protein McI-1, inducing apoptosis, and causing cell cycle arrest at the G2/M phase. This compound is applicable in the research of acute myeloid leukemia (AML) .
Field of Research
Cell Biology, Epigenetics & Chromatin
Molecular Formula
C20H19FN2O4S2
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR18187313CDK9 Antibody
GTR19243952-01CDK9-IN-15
GTR19235891-01CDK9-IN-31
GTR19231013-01CDK9-IN-27
GTR19230339-01CDK9-IN-28
GTR19206276-01CDK9-IN-10
GTR19272875-01CDK9-IN-42
GTR17918794-01CDK9 Antibody
GTR18593597-01CDK9 Antibody

Alternative Products

CatalogName
HY-173481CDK9-IN-37
030081CDK9
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
HY-130852-01CDK9-IN-11
70R-10466CDK9 antibody
T205526-01CDK9-IN-36
T201179-01CDK9-IN-35

Popular Products